BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that it will deliver a poster presentation at the 53rd Annual Meeting of ASH, the American Society of Hematology. The conference will be held December 10-13th, 2011 at the San Diego Convention Center in San Diego, California. The Company will present during the Oral and Poster Abstracts Program that will begin Saturday December 10th, at 5:30 p.m. Pacific Time. The poster presentation, entitled “Pharmacodynamic, Biodistribution and Toxicology Results for SNS01-T, a Nanoparticle That Targets eIF5A for the Treatment of Multiple Myeloma”, will describe the characteristics of SNS01-T, which is the subject of an on-going clinical study at the Mayo Clinic. The poster will be presented by Catherine Taylor, Research Associate from Senesco CSO John Thompson’s research laboratory at the University of Waterloo in Ontario, Canada. Additional details about the conference can be found at: http://www.hematology.org
